tirzepatide plm FDA approves tirzepatide, Eli Lilly's new type 2 diabetes drug, and the company shares an estimated price Next Health Fredericksburg - Regenerative
Description
However, when compared to SGLT2 inhibitors, GLP-1 receptor agonists are less effective for kidney outcomes, including albuminuria and eGFR decline, but remain superior to DPP-4 inhibitors, sulfonylureas, and basal insulin [143,144]
Recent data show that GLP-1 prescriptions for weight loss have surged, with usage increasing nearly 587 % between 2019 and 2024 , reflecting strong ongoing GLP-1 demand in the U.S
GLP-1 agonists reduce appetite , which contributes to their role in weight management
A.KhokhlovA
